Market Research Logo

Conference Documentation: Alzheimer's

Conference Documentation: Alzheimer's

SMi will present their inaugural conference on Alzheimer’s Disease 2016, which is one of the most threatening diseases that accompanies age, yet formidably mysterious in biology.

This conference will cover: Pre-clinical assessment criteria for AD diagnosis such as risk profiling, population group assessment and stages of AD progression. How do external stimuli play influence studies and outcome?

Furthermore, emerging frontiers in biomarker development to aid more accurate diagnosis and tracking of tau-mediated neuronal death will help further drug development as well as providing more answers into how AD occurs, and most importantly when.

The conference will gather leading researchers and clinical managers to discuss models, diagnostic imaging and novel therapeutic platforms.


Day 1
8:30
Registration & Coffee
9:00
Chairman's opening remarks
Giulio Maria Pasinetti, Saunders Family Chair and Professor of Neurology, Icahn School of Medicine at Mount Sinai
9:10
OPENING ADDRESS: Addressing the under-met areas of research and diagnosis
Giulio Maria Pasinetti, Saunders Family Chair and Professor of Neurology, Icahn School of Medicine at Mount Sinai
9:50
The EPAD Project - Changing the way therapies are developed for the secondary prevention of Alzheimer’s dementia
Serge Van der Geyten, Director, Neuroscience External Affairs, Janssen Research & Development
10:30
Morning Coffee
11:00
Risk profiling Alzheimer’s disease
Graciela Muniz Terrera , Senior Lecturer Biostatistics, University Of Edinburgh
11:40
Beyond cognition – behavioural and psychiatric symptoms in Alzheimer’s disease
Sophie Dix , Director of Research , MQ Transforming Mental Health
12:20
Networking Lunch
13:30
Delivering macromolecules across the blood brain barrier – An alternative to small molecule drugs?
Steven Hood, Director, Biotransformation & Drug Disposition, GSK
14:10
KEYNOTE ADDRESS: Tau aggregation inhibition as a target for Alzheimer's disease and related late life neurodegenerative disorders
Claude M Wischik, Executive Chairman , TauRx Therapeutics
14:50
Afternoon Tea
15:20
Funding investment and research
Simon Ridley, Director of Research, Alzheimer’s Research UK
16:00
Chairman’s closing remarks and close of day one
Giulio Maria Pasinetti, Saunders Family Chair and Professor of Neurology, Icahn School of Medicine at Mount Sinai
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Giulio Maria Pasinetti, Saunders Family Chair and Professor of Neurology, Icahn School of Medicine at Mount Sinai
9:10
KEYNOTE ADRESS: Translatable research of cognitive decline from animals to humans
Luc Ver Donck, Scientific Director , Janssen Research & Development
9:50
Specific targeting of synapse-damaging oligomers of amyloid-beta with AßCC technology
Anders Sandberg, CSO, Alzinova AB
10:30
Morning Coffee
11:00
Representing clinically-meaningful data from a disease-modifying drug trial
Alan Lenox Smith, Senior Clinical Research Physician , Eli Lilly
11:40
Regulatory view on the efficacy endpoints and safety assessment
John Warren, Director, Medicines Assessment Ltd
12:20
Networking Lunch
13:30
KEYNOTE ADDRESS: The use of transgenic models in drug discovery: Focus on tau pathology
Michael J O'Neill, Head of Molecular Pathology Group, Eli Lilly
14:10
IMI project on the development of a European Medical Information Framework for Alzheimer's disease
Pieter Jelle Visser, Senior Researcher, VU University Medical Center
14:50
Clearance of misfolded proteins and microglial activation
Michael Heneka, Head Neurologist , University Hospital Bonn
15:30
Afternoon Tea
16:00
In vivo multi parametric MRI imaging of tau pathology in mice
Jack Wells, Project Lead MRI Neuroimaging, UCL
16:40
Understanding AD pathogenesis in Down’s syndrome
Shahid Zaman, Affiliated lecturer & Consultant Psychiatrist, University of Cambridge
17:20
Chairman’s Closing Remarks and Close of Day Two
Giulio Maria Pasinetti, Saunders Family Chair and Professor of Neurology, Icahn School of Medicine at Mount Sinai

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report